Prime Medicine, Inc. (PRME) Free cash flow 2020–2025
Prime Medicine, Inc. (PRME) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$167.1MFY2025 · since FY2020: -$6.2M → -$167.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$167.1M | -28.4% |
| FY2024 | -$130.2M | +25.3% |
| FY2023 | -$174.1M | -17.7% |
| FY2022 | -$147.9M | -286.9% |
| FY2021 | -$38.2M | -518.3% |
| FY2020 | -$6.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating incomePRME Operating marginPRME Operating cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →